細(xì)胞療法在肝臟疾病臨床治療中的應(yīng)用及展望

摘要：細(xì)胞療法是區(qū)別于傳統(tǒng)藥物的新興療法，其中免疫細(xì)胞和間充質(zhì)干細(xì)胞是目前治療肝臟疾病最有前景的兩類(lèi)細(xì)胞，其展現(xiàn)的治療效果已經(jīng)初見(jiàn)成效。本文對(duì)肝臟疾病領(lǐng)域相關(guān)的細(xì)胞療法進(jìn)展進(jìn)行總結(jié)，分析不同細(xì)胞療法的挑戰(zhàn)和應(yīng)對(duì)策略，并對(duì)細(xì)胞療法在肝臟相關(guān)疾病中的應(yīng)用前景進(jìn)行展望。

關(guān)鍵詞：肝疾?。?細(xì)胞療法； 間充質(zhì)干細(xì)胞； 過(guò)繼細(xì)胞療法

Abstract：Cell therapy is an emerging therapy different from traditional drug therapy， among which immune cells and mesenchymal stem cells are the two types of most promising cells in the treatment of liver diseases at present， and preliminary results have been achieved for their therapeutic effects. This article summarizes the advances in cell therapy in the field of liver diseases， analyzes the challenges and coping strategies of different cell therapies， and discusses the application prospects of cell therapy in liver-related diseases.

Key words：Liver Diseases;  Cell Therapy; Mesenchymal Stem Cells； Adoptive Cell Therapy

1 免疫細(xì)胞療法在肝癌治療中的應(yīng)用

肝細(xì)胞癌（hepatocellular carcinoma， HCC）目前是全球第五大常見(jiàn)惡性腫瘤，也是癌癥相關(guān)死亡的第三大主要原因。（剩余4961字）